Breaking News Instant updates and real-time market news.

04:55
01/08/21
01/08
04:55
01/08/21
04:55

Credit Suisse to hold a virtual conference

12th CS ASEAN Virtual Conference in collaboration with ASEAN Exchanges will be held on January 4-8.

TODAY'S FREE FLY STORIES

Hot Stocks
Colliers launches global partnership with Blue Skyre to innovate its services » 07:35
06/24/21
06/24
07:35
06/24/21
07:35
CIGI

Colliers International

$116.32 /

+0.08 (+0.07%)

Colliers announced a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CIGI Colliers International
$116.32 /

+0.08 (+0.07%)

CIGI Colliers International
$116.32 /

+0.08 (+0.07%)

02/16/21 TD Securities
Colliers International price target raised to $125 from $100 at TD Securities
02/16/21 RBC Capital
Colliers International price target raised to $126 from $96 at RBC Capital
02/16/21 RBC Capital
Colliers International price target raised to $126 from $96 at RBC Capital
01/25/21
Fly Intel: Top five analyst initiations
CIGI Colliers International
$116.32 /

+0.08 (+0.07%)

CIGI Colliers International
$116.32 /

+0.08 (+0.07%)

Options
Unusual call flow in option market yesterday » 07:35
06/24/21
06/24
07:35
06/24/21
07:35
BIDU

Baidu

$189.16 /

+1.61 (+0.86%)

Notable call activity was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BIDU Baidu
$189.16 /

+1.61 (+0.86%)

BIDU Baidu
$189.16 /

+1.61 (+0.86%)

06/01/21 Mizuho
Baidu remains top China internet pick at Mizuho
05/20/21 Susquehanna
Baidu price target lowered to $250 from $450 at Susquehanna
05/20/21 Morgan Stanley
Baidu price target lowered to $230 from $300 at Morgan Stanley
05/20/21 HSBC
Baidu price target lowered to $295 from $374 at HSBC
BIDU Baidu
$189.16 /

+1.61 (+0.86%)

  • 26
    Mar
BIDU Baidu
$189.16 /

+1.61 (+0.86%)

BIDU Baidu
$189.16 /

+1.61 (+0.86%)

BIDU Baidu
$189.16 /

+1.61 (+0.86%)

Hot Stocks
Innovid to become publicly listed via merger with ION Acquisition Corp 2 » 07:34
06/24/21
06/24
07:34
06/24/21
07:34
IACB

ION Acquisition Corp 2

$10.00 /

+ (+0.00%)

Innovid announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IACB ION Acquisition Corp 2
$10.00 /

+ (+0.00%)

Recommendations
B. Riley ups WideOpenWest target, says valuation discount 'overly punitive' » 07:34
06/24/21
06/24
07:34
06/24/21
07:34
WOW

WideOpenWest

$17.44 /

-0.04 (-0.23%)

, CABO

Cable One

$1,850.00 /

-15.1 (-0.81%)

B. Riley analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WOW WideOpenWest
$17.44 /

-0.04 (-0.23%)

CABO Cable One
$1,850.00 /

-15.1 (-0.81%)

WOW WideOpenWest
$17.44 /

-0.04 (-0.23%)

06/03/21 Benchmark
WideOpenWest initiated with a Buy at Benchmark
05/14/21 B. Riley
WideOpenWest resumed with a Buy at B. Riley
05/06/21 Stephens
Stephens upgrades WideOpenWest to Overweight, bets on asset sale
05/06/21 Stephens
WideOpenWest upgraded to Overweight from Equal Weight at Stephens
CABO Cable One
$1,850.00 /

-15.1 (-0.81%)

03/16/21 Wells Fargo
Wells starts Cable One at Overweight, sees 'so much to like'
03/16/21 Wells Fargo
Cable One initiated with an Overweight at Wells Fargo
03/08/21 Raymond James
Cable One upgraded to Outperform from Market Perform at Raymond James
03/08/21 Truist
Cable One upgraded to Buy from Hold at Truist
WOW WideOpenWest
$17.44 /

-0.04 (-0.23%)

CABO Cable One
$1,850.00 /

-15.1 (-0.81%)

WOW WideOpenWest
$17.44 /

-0.04 (-0.23%)

CABO Cable One
$1,850.00 /

-15.1 (-0.81%)

Hot Stocks
Intellia Therapeutics names Basta as Executive Vice President » 07:32
06/24/21
06/24
07:32
06/24/21
07:32
NTLA

Intellia Therapeutics

$83.61 /

+4.65 (+5.89%)

, KURA

Kura Oncology

$21.43 /

-0.1 (-0.46%)

Intellia Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NTLA Intellia Therapeutics
$83.61 /

+4.65 (+5.89%)

KURA Kura Oncology
$21.43 /

-0.1 (-0.46%)

NTLA Intellia Therapeutics
$83.61 /

+4.65 (+5.89%)

06/23/21 Baird
Intellia Therapeutics price target raised to $85 from $60 at Baird
06/23/21 JMP Securities
Intellia Therapeutics price target raised to $88 from $80 at JMP Securities
06/22/21 Jefferies
Intellia price target raised to $109 at Jefferies ahead of '2001 data report
06/11/21
Fly Intel: Top five analyst initiations
KURA Kura Oncology
$21.43 /

-0.1 (-0.46%)

05/04/21 Credit Suisse
Kura Oncology assumed with an Outperform at Credit Suisse
04/26/21 Credit Suisse
Kura Oncology assumed with an Outperform at Credit Suisse
02/24/21 Piper Sandler
Kura Oncology price target lowered to $30 from $34 at Piper Sandler
02/24/21 H.C. Wainwright
H.C. Wainwright trims Kura Oncology price target to $43 after Q4 report
NTLA Intellia Therapeutics
$83.61 /

+4.65 (+5.89%)

KURA Kura Oncology
$21.43 /

-0.1 (-0.46%)

  • 09
    Dec
  • 02
    Dec
KURA Kura Oncology
$21.43 /

-0.1 (-0.46%)

Initiation
B. Riley starts Skillsoft at Buy with turnaround in final stages » 07:30
06/24/21
06/24
07:30
06/24/21
07:30
SKIL

Skillsoft

$9.73 /

-0.275 (-2.75%)

B. Riley analyst Raj…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SKIL Skillsoft
$9.73 /

-0.275 (-2.75%)

SKIL Skillsoft
$9.73 /

-0.275 (-2.75%)

06/23/21 B. Riley
Skillsoft initiated with a Buy at B. Riley
06/22/21 Citi
Skillsoft initiated with a Buy at Citi
SKIL Skillsoft
$9.73 /

-0.275 (-2.75%)

Hot Stocks
Fulcrum Therapeutics Inc trading resumes  07:30
06/24/21
06/24
07:30
06/24/21
07:30
FULC

Fulcrum Therapeutics

$9.13 /

+0.25 (+2.82%)

 
ShowHide Related Items >><<
FULC Fulcrum Therapeutics
$9.13 /

+0.25 (+2.82%)

FULC Fulcrum Therapeutics
$9.13 /

+0.25 (+2.82%)

04/26/21 Credit Suisse
Fulcrum Therapeutics assumed with an Outperform at Credit Suisse
03/22/21 Credit Suisse
Fulcrum Therapeutics initiated with an Outperform at Credit Suisse
03/04/21 Piper Sandler
Fulcrum Therapeutics price target lowered to $20 from $22 at Piper Sandler
03/01/21 Stifel
Fulcrum Therapeutics initiated with a Buy at Stifel
FULC Fulcrum Therapeutics
$9.13 /

+0.25 (+2.82%)

  • 20
    Jan
Hot Stocks
EU commercial vehicle registrations up 51.3% in May » 07:29
06/24/21
06/24
07:29
06/24/21
07:29
DDAIF

Daimler AG

$93.52 /

-1.49 (-1.57%)

, PCAR

Paccar

$87.74 /

+0.36 (+0.41%)

, CNHI

CNH Industrial

$16.14 /

-0.17 (-1.04%)

, NAV

Navistar

$44.47 /

+0.02 (+0.04%)

, CMI

Cummins

$238.02 /

+0.94 (+0.40%)

, ALSN

Allison Transmission

$39.15 /

+ (+0.00%)

In May, the EU commercial…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DDAIF Daimler AG
$93.52 /

-1.49 (-1.57%)

PCAR Paccar
$87.74 /

+0.36 (+0.41%)

CNHI CNH Industrial
$16.14 /

-0.17 (-1.04%)

NAV Navistar
$44.47 /

+0.02 (+0.04%)

CMI Cummins
$238.02 /

+0.94 (+0.40%)

ALSN Allison Transmission
$39.15 /

+ (+0.00%)

DDAIF Daimler AG
$93.52 /

-1.49 (-1.57%)

05/21/21 UBS
Daimler AG price target raised to EUR 79 from EUR 78 at UBS
04/26/21 Barclays
Daimler AG price target raised to EUR 115 from EUR 100 at Barclays
04/26/21 JPMorgan
Daimler AG price target raised to EUR 100 from EUR 92 at JPMorgan
04/26/21 Deutsche Bank
Daimler AG price target raised to EUR 85 from EUR 80 at Deutsche Bank
PCAR Paccar
$87.74 /

+0.36 (+0.41%)

05/12/21 Evercore ISI
Paccar price target raised to $115 from $111 at Evercore ISI
05/04/21 BMO Capital
Paccar price target raised to $95 from $90 at BMO Capital
04/28/21 Deutsche Bank
Paccar price target raised to $98 from $91 at Deutsche Bank
01/20/21 Vertical Research
Paccar initiated with a Hold at Vertical Research
CNHI CNH Industrial
$16.14 /

-0.17 (-1.04%)

06/21/21 Baird
CNH deal for Raven a long-term positive for dealer Titan, says Baird
05/12/21 Evercore ISI
CNH Industrial price target raised to $25 from $18 at Evercore ISI
05/07/21 BofA
CNH Industrial added to US 1 List at BofA
04/23/21 AlphaValue
CNH Industrial upgraded to Add from Sell at AlphaValue
NAV Navistar
$44.47 /

+0.02 (+0.04%)

10/23/20 Jefferies
Navistar downgraded to Hold after Traton takeover deal at Jefferies
10/23/20 Jefferies
Navistar downgraded to Hold from Buy at Jefferies
10/14/20 Loop Capital
Navistar downgraded to Hold from Buy at Loop Capital
09/15/20 UBS
Navistar price target raised to $43 from $29 at UBS
CMI Cummins
$238.02 /

+0.94 (+0.40%)

05/17/21
Fly Intel: Top five analyst upgrades
05/17/21 BofA
BofA upgrades Cummins to Buy, sees continued outperformance
05/17/21 BofA
Cummins upgraded to Buy from Neutral at BofA
05/12/21 Evercore ISI
Cummins price target raised to $358 from $291 at Evercore ISI
ALSN Allison Transmission
$39.15 /

+ (+0.00%)

06/01/21
Fly Intel: Top five analyst downgrades
05/31/21 Goldman Sachs
Allison Transmission downgraded to Sell from Buy at Goldman Sachs
04/21/21 Raymond James
Allison Transmission downgraded to Market Perform from Strong Buy at Raymond James
04/21/21 Raymond James
Allison downgraded to Market Perform from Strong Buy at Raymond James
DDAIF Daimler AG
$93.52 /

-1.49 (-1.57%)

PCAR Paccar
$87.74 /

+0.36 (+0.41%)

CNHI CNH Industrial
$16.14 /

-0.17 (-1.04%)

NAV Navistar
$44.47 /

+0.02 (+0.04%)

CMI Cummins
$238.02 /

+0.94 (+0.40%)

ALSN Allison Transmission
$39.15 /

+ (+0.00%)

DDAIF Daimler AG
$93.52 /

-1.49 (-1.57%)

CMI Cummins
$238.02 /

+0.94 (+0.40%)

DDAIF Daimler AG
$93.52 /

-1.49 (-1.57%)

PCAR Paccar
$87.74 /

+0.36 (+0.41%)

CNHI CNH Industrial
$16.14 /

-0.17 (-1.04%)

NAV Navistar
$44.47 /

+0.02 (+0.04%)

CMI Cummins
$238.02 /

+0.94 (+0.40%)

PCAR Paccar
$87.74 /

+0.36 (+0.41%)

Conference/Events
Encompass Health to host conference call » 07:29
06/24/21
06/24
07:29
06/24/21
07:29
EHC

Encompass Health

$80.15 /

-0.62 (-0.77%)

Management holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EHC Encompass Health
$80.15 /

-0.62 (-0.77%)

EHC Encompass Health
$80.15 /

-0.62 (-0.77%)

04/29/21 Mizuho
Encompass Health price target raised to $94 from $90 at Mizuho
04/19/21 Gordon Haskett
Encompass Health jet found back in home state of CVS, says Gordon Haskett
04/08/21 Gordon Haskett
Gordon Haskett highlights Encompass Health's 'interesting' Rhode Island trip
01/28/21 Credit Suisse
Encompass Health price target lowered to $92 from $97 at Credit Suisse
EHC Encompass Health
$80.15 /

-0.62 (-0.77%)

EHC Encompass Health
$80.15 /

-0.62 (-0.77%)

Syndicate
Talos Energy 5M share Spot Secondary priced at $17.50 » 07:28
06/24/21
06/24
07:28
06/24/21
07:28
TALO

Talos Energy

$18.60 /

+0.47 (+2.59%)

The deal priced below…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TALO Talos Energy
$18.60 /

+0.47 (+2.59%)

TALO Talos Energy
$18.60 /

+0.47 (+2.59%)

06/08/21
Fly Intel: Top five analyst initiations
06/08/21 Citi
Talos Energy initiated with a Buy at Citi
05/03/21 Roth Capital
Talos Energy price target raised to $18 from $13 at Roth Capital
04/13/21 Stifel
BP discovery holds over 100MMboe of potential net to Talos interest, says Stifel
TALO Talos Energy
$18.60 /

+0.47 (+2.59%)

  • 24
    Jun
  • 09
    Dec
TALO Talos Energy
$18.60 /

+0.47 (+2.59%)

TALO Talos Energy
$18.60 /

+0.47 (+2.59%)

Recommendations
National CineMedia price target raised to $7 from $6 at B. Riley » 07:28
06/24/21
06/24
07:28
06/24/21
07:28
NCMI

National CineMedia

$4.84 /

+0.12 (+2.54%)

B. Riley analyst Eric…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NCMI National CineMedia
$4.84 /

+0.12 (+2.54%)

NCMI National CineMedia
$4.84 /

+0.12 (+2.54%)

06/07/21 B. Riley
Box office trends improving into summer, says B. Riley
04/07/21
Fly Intel: Top five analyst upgrades
04/07/21 Benchmark
National CineMedia upgraded to Buy from Hold at Benchmark
03/24/21 B. Riley Securities
Disney 'day-and-date' decision negative for exhibitors, says B. Riley
NCMI National CineMedia
$4.84 /

+0.12 (+2.54%)

NCMI National CineMedia
$4.84 /

+0.12 (+2.54%)

NCMI National CineMedia
$4.84 /

+0.12 (+2.54%)

Earnings
Vera Therapeutics reports Q1 EPS ($12.23) vs. ($7.79) last year » 07:28
06/24/21
06/24
07:28
06/24/21
07:28
VERA

Vera Therapeutics

$15.83 /

+ (+0.00%)

"Over the past nine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VERA Vera Therapeutics
$15.83 /

+ (+0.00%)

VERA Vera Therapeutics
$15.83 /

+ (+0.00%)

06/08/21 Jefferies
Vera Therapeutics initiated with Buy, $27 target at Jefferies
06/08/21 Evercore ISI
Vera Therapeutics initiated with an Outperform at Evercore ISI
06/08/21 Jefferies
Vera Therapeutics initiated with a Buy at Jefferies
06/08/21 Cowen
Vera Therapeutics initiated with an Outperform at Cowen
  • 14
    May
VERA Vera Therapeutics
$15.83 /

+ (+0.00%)

Conference/Events
Sempra Energy to host virtual investor day » 07:27
06/24/21
06/24
07:27
06/24/21
07:27
SRE

Sempra Energy

$135.56 /

-1.36 (-0.99%)

Virtual Investor Day to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SRE Sempra Energy
$135.56 /

-1.36 (-0.99%)

SRE Sempra Energy
$135.56 /

-1.36 (-0.99%)

05/25/21 Barclays
Sempra Energy price target raised to $158 from $145 at Barclays
05/06/21 Wells Fargo
Sempra Energy price target raised to $148 from $139 at Wells Fargo
04/19/21
Fly Intel: Top five analyst upgrades
04/19/21 Mizuho
Sempra Energy upgraded to Buy from Neutral at Mizuho
SRE Sempra Energy
$135.56 /

-1.36 (-0.99%)

SRE Sempra Energy
$135.56 /

-1.36 (-0.99%)

Recommendations
GT Biopharma price target raised to $26 from $21 at B. Riley » 07:27
06/24/21
06/24
07:27
06/24/21
07:27
GTBP

GT Biopharma

$15.24 /

-0.205 (-1.33%)

B. Riley analyst Justin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GTBP GT Biopharma
$15.24 /

-0.205 (-1.33%)

GTBP GT Biopharma
$15.24 /

-0.205 (-1.33%)

05/24/21 H.C. Wainwright
GT Biopharma initiated with a Buy at H.C. Wainwright
04/13/21 B. Riley
B. Riley starts GT Biopharma with Buy, sees 101% upside in shares
04/13/21 B. Riley
GT Biopharma initiated with a Buy at B. Riley
03/17/21 Roth Capital
GT Biopharma initiated with a Buy at Roth Capital
  • 11
    Feb
GTBP GT Biopharma
$15.24 /

-0.205 (-1.33%)

Hot Stocks
Agrify expands relationship with Nevada Holistic Medicine » 07:26
06/24/21
06/24
07:26
06/24/21
07:26
AGFY

Agrify

$11.67 /

+0.47 (+4.20%)

Agrify Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGFY Agrify
$11.67 /

+0.47 (+4.20%)

AGFY Agrify
$11.67 /

+0.47 (+4.20%)

03/01/21 Maxim
Agrify initiated with a Buy at Maxim
02/23/21 Roth Capital
Agrify initiated with a Buy at Roth Capital
AGFY Agrify
$11.67 /

+0.47 (+4.20%)

  • 17
    Feb
  • 28
    Jan
AGFY Agrify
$11.67 /

+0.47 (+4.20%)

Conference/Events
Jones Lang LaSalle to host investor webcast » 07:26
06/24/21
06/24
07:26
06/24/21
07:26
JLL

Jones Lang LaSalle

$203.04 /

-0.18 (-0.09%)

Sustainability Investor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JLL Jones Lang LaSalle
$203.04 /

-0.18 (-0.09%)

JLL Jones Lang LaSalle
$203.04 /

-0.18 (-0.09%)

06/14/21 Wolfe Research
Jones Lang LaSalle initiated with an Outperform at Wolfe Research
05/06/21 JPMorgan
Jones Lang LaSalle price target raised to $219 from $200 at JPMorgan
02/26/21 JPMorgan
Jones Lang LaSalle price target raised to $200 from $176 at JPMorgan
01/25/21 Goldman Sachs
Jones Lang LaSalle initiated with a Buy at Goldman Sachs
JLL Jones Lang LaSalle
$203.04 /

-0.18 (-0.09%)

JLL Jones Lang LaSalle
$203.04 /

-0.18 (-0.09%)

Initiation
Chesswood Group initiated with an Outperform at Raymond James » 07:25
06/24/21
06/24
07:25
06/24/21
07:25
CHWWF

Chesswood Group

$11.00 /

+ (+0.00%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Initiation
Needham starts 'preeminent franchise' Analog Devices with Buy rating » 07:25
06/24/21
06/24
07:25
06/24/21
07:25
ADI

Analog Devices

$163.60 /

-0.13 (-0.08%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADI Analog Devices
$163.60 /

-0.13 (-0.08%)

ADI Analog Devices
$163.60 /

-0.13 (-0.08%)

06:30 Today Needham
Analog Devices initiated with a Buy at Needham
05/20/21 Truist
Analog Devices price target lowered to $179 from $183 at Truist
05/20/21 Deutsche Bank
Analog Devices price target raised to $165 from $160 at Deutsche Bank
05/20/21 Bernstein
Analog Devices upgraded to Outperform from Market Perform at Bernstein
ADI Analog Devices
$163.60 /

-0.13 (-0.08%)

ADI Analog Devices
$163.60 /

-0.13 (-0.08%)

ADI Analog Devices
$163.60 /

-0.13 (-0.08%)

ADI Analog Devices
$163.60 /

-0.13 (-0.08%)

Hot Stocks
Corvus Gold announces additional results from Mother Lode program » 07:25
06/24/21
06/24
07:25
06/24/21
07:25
KOR

Corvus Gold

$2.68 /

+0.02 (+0.75%)

Corvus Gold announces it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KOR Corvus Gold
$2.68 /

+0.02 (+0.75%)

KOR Corvus Gold
$2.68 /

+0.02 (+0.75%)

04/15/21 BMO Capital
Corvus Gold initiated with an Outperform at BMO Capital
Recommendations
Winnebago price target lowered to $86 from $94 at Wedbush » 07:24
06/24/21
06/24
07:24
06/24/21
07:24
WGO

Winnebago

$65.98 /

-0.825 (-1.23%)

Wedbush analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WGO Winnebago
$65.98 /

-0.825 (-1.23%)

WGO Winnebago
$65.98 /

-0.825 (-1.23%)

06:35 Today Baird
Winnebago elevated to bullish Fresh Pick at Baird
06/17/21 Northcoast
Northcoast downgrades three RV makers to Neutral following industry checks
06/17/21 Northcoast
Winnebago downgraded to Neutral from Buy at Northcoast
05/03/21 Citi
Winnebago price target raised to $93 from $73 at Citi
WGO Winnebago
$65.98 /

-0.825 (-1.23%)

WGO Winnebago
$65.98 /

-0.825 (-1.23%)

Hot Stocks
4D Molecular announces expected upcoming milestones » 07:23
06/24/21
06/24
07:23
06/24/21
07:23
FDMT

4D Molecular

$24.81 /

+0.91 (+3.81%)

4D-125: Initial biologic…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FDMT 4D Molecular
$24.81 /

+0.91 (+3.81%)

FDMT 4D Molecular
$24.81 /

+0.91 (+3.81%)

01/05/21 Evercore ISI
4D Molecular initiated with an Outperform at Evercore ISI
01/05/21 BofA
4D Molecular initiated with a Buy at BofA
01/05/21 Goldman Sachs
4D Molecular initiated with a Neutral at Goldman Sachs
  • 11
    Dec
FDMT 4D Molecular
$24.81 /

+0.91 (+3.81%)

Hot Stocks
4D Molecular announces initial safety data for 4D-110, 4D-125 » 07:23
06/24/21
06/24
07:23
06/24/21
07:23
FDMT

4D Molecular

$24.81 /

+0.91 (+3.81%)

4D Molecular Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FDMT 4D Molecular
$24.81 /

+0.91 (+3.81%)

FDMT 4D Molecular
$24.81 /

+0.91 (+3.81%)

01/05/21 Evercore ISI
4D Molecular initiated with an Outperform at Evercore ISI
01/05/21 BofA
4D Molecular initiated with a Buy at BofA
01/05/21 Goldman Sachs
4D Molecular initiated with a Neutral at Goldman Sachs
  • 11
    Dec
FDMT 4D Molecular
$24.81 /

+0.91 (+3.81%)

Hot Stocks
Eli Lilly jumps on expedited plans for Alzheimer's drug, Biogen falls » 07:22
06/24/21
06/24
07:22
06/24/21
07:22
LLY

Eli Lilly

$217.08 /

-4.51 (-2.04%)

, BIIB

Biogen

$371.82 /

-2.77 (-0.74%)

Eli Lilly (LLY) announced…

Eli Lilly (LLY) announced that the Food and Drug Administration granted Breakthrough Therapy designation for donanemab, its investigational antibody therapy for Alzheimer's disease. Lilly intends to submit a biologics license application for donanemab under the accelerated approval pathway later this year based on data from TRAILBLAZER-ALZ. The safety, tolerability and efficacy of donanemab are also being evaluated in the ongoing Phase 3 study TRAILBLAZER-ALZ 2, the company said in a statement. The Phase 2 trial, TRAILBLAZER-ALZ, studied the efficacy and safety of donanemab in patients with early, symptomatic Alzheimer's. Shares of Eli Lilly are up 9%, or $18.50, to $235.60 following the news. Shares of Biogen (BIIB), who recently received FDA approval for its Alzheimer's treatment, are down 6% to $350.02 in premarket trading.

ShowHide Related Items >><<
LLY Eli Lilly
$217.08 /

-4.51 (-2.04%)

BIIB Biogen
$371.82 /

-2.77 (-0.74%)

LLY Eli Lilly
$217.08 /

-4.51 (-2.04%)

06/15/21 JPMorgan
Eli Lilly price target raised to $260 from $240 at JPMorgan
06/14/21 Goldman Sachs
Eli Lilly price target raised to $270 from $252 at Goldman Sachs
06/08/21 Baird
Baird upgrades Biogen to Neutral after 'fatal blow' to bear thesis
06/07/21 BofA
BofA upgrades Biogen to Neutral with $400 price target after Aduhelm approved
BIIB Biogen
$371.82 /

-2.77 (-0.74%)

06/18/21
Fly Intel: Top five analyst upgrades
06/18/21 Jefferies
Jefferies a buyer of Prothena on Biogen's negative Tau disappointment pullback
06/18/21 BofA
BofA upgrades Prothena to Neutral on PRX012 potential following Aduhelm approval
06/18/21 Piper Sandler
Biogen upgraded to Overweight from Neutral at Piper Sandler
LLY Eli Lilly
$217.08 /

-4.51 (-2.04%)

BIIB Biogen
$371.82 /

-2.77 (-0.74%)

LLY Eli Lilly
$217.08 /

-4.51 (-2.04%)

BIIB Biogen
$371.82 /

-2.77 (-0.74%)

LLY Eli Lilly
$217.08 /

-4.51 (-2.04%)

BIIB Biogen
$371.82 /

-2.77 (-0.74%)

LLY Eli Lilly
$217.08 /

-4.51 (-2.04%)

BIIB Biogen
$371.82 /

-2.77 (-0.74%)

Hot Stocks
Aileron Therapeutics set to join Russell Microcap Index » 07:21
06/24/21
06/24
07:21
06/24/21
07:21
ALRN

Aileron Therapeutics

$1.28 /

+0.04 (+3.23%)

Aileron Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALRN Aileron Therapeutics
$1.28 /

+0.04 (+3.23%)

ALRN Aileron Therapeutics
$1.28 /

+0.04 (+3.23%)

Initiation
Truist starts Taysha Gene Therapies at Buy on potential de-risking events » 07:21
06/24/21
06/24
07:21
06/24/21
07:21
TSHA

Taysha Gene Therapies

$25.25 /

+0.07 (+0.28%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSHA Taysha Gene Therapies
$25.25 /

+0.07 (+0.28%)

TSHA Taysha Gene Therapies
$25.25 /

+0.07 (+0.28%)

06:12 Today Truist
Taysha Gene Therapies initiated with a Buy at Truist
06/14/21 BTIG
Taysha Gene Therapies initiated with a Buy at BTIG
06/09/21 Wedbush
Taysha Gene Therapies initiated with an Outperform at Wedbush
06/08/21 JMP Securities
Taysha Gene Therapies initiated with an Outperform at JMP Securities
TSHA Taysha Gene Therapies
$25.25 /

+0.07 (+0.28%)

  • 24
    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.